In acute intermittent porphyria (AIP), the deficiency of the enzyme hydroxymethylbilane synthase (HMBS), also known as porphobilinogen deaminase (PBGD), could be addressed by administrating an ERT based on HMBS/PBGD [43]. This evidence concerns the gene HMBS and acute intermittent porphyria.